ExodusPoint Capital Management’s Tectonic Therapeutic TECX Stock Holding History

ExodusPoint Capital Management’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59M	Sell	83,679 -27,509	-25%	-$677K	0.02%	669
2025 Q4	$2.32M	Buy	111,188 +98,171	+754%	+$1.82M	0.02%	720
2025 Q3	$204K	Buy	+13,017	New	+$269K	﹤0.01%	1384
2022 Q2	–	Sell	-877	Closed	-$14K	–	2543
2022 Q1	$14K	Sell	877 -230	-21%	-$4.75K	﹤0.01%	2113
2021 Q4	$51K	Sell	1,107 -967	-47%	-$55.6K	﹤0.01%	2030
2021 Q3	$139K	Buy	2,074 +381	+23%	+$31.3K	﹤0.01%	1854
2021 Q2	$181K	Buy	+1,693	New	+$201K	﹤0.01%	2020

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

ExodusPoint Capital Management's TECX Position: Q1 2026 in Review

ExodusPoint Capital Management reduced its Tectonic Therapeutic (TECX) stake by 25% in Q1 2026, selling an estimated $677K and leaving 83,679 shares worth $2.59M. The position accounts for 0.02% of the portfolio, ranked #669.

ExodusPoint Capital Management first reported a position in TECX in Q2 2021 and has held it in 7 quarters since. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

ExodusPoint Capital Management held 83,679 shares of Tectonic Therapeutic worth $2.59M as of Q1 2026.
ExodusPoint Capital Management sold 27,509 Tectonic Therapeutic shares in Q1 2026, an estimated $677K.
Tectonic Therapeutic made up 0.02% of ExodusPoint Capital Management's portfolio in Q1 2026, its #669 holding.
ExodusPoint Capital Management first reported a position in Tectonic Therapeutic in Q2 2021 and has held it in 7 quarters since.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.